• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Research > Technology Transfer > Examples of Recent Technology Transfer Initiatives > MORPHEUS III protein crystallization screen (2017)

MORPHEUS III protein crystallization screen (2017)

MORPHEUS III is a 96-condition 3D grid screen for protein crystallisation invented at the MRC Laboratory of Molecular Biology by Dr Fabrice Gorrec. The screen has been formulated to solve novel structures of proteins and macromolecular complexes. For this, the main ideas behind the formulation of MORPHEUS I (2009) and MORPHEUS II (2015) were followed, with essentially:

  • to increase the yield of quality diffraction crystals by integrating mixes of additives that can act as protein stabilisers, crystal cross-linkers, etc. (a feature initially investigated by McPherson & Cudney in 2006 for their ‘Silver Bullets’ screen).
  • systematic approaches to select the reagents and formulate the screen, like the integration of ligands that are found in crystal structures of the Protein Data Bank (PDB).
  • considering pragmatic aspects that facilitate the steps towards structure solution. For example, cryoprotectants are integrated for straightforward flash-freezing of crystals.
  • testing formulation prototypes on a broad range of samples purified at the LMB in order to avoid biases towards a specific subset/class of targets.

The novelty in MORPHEUS III is based on the integration of small drug-like compounds as additives (some of which were found in other databases than the PDB). The final formulation of the new 96-condition crystallisation screen integrates 44 compounds overall selected for their relative stability and solubility. These compounds were divided in 8 mixes of additives in order to formulate the typical MORPHEUS 3D grid screen where each mix of additive is combined with 4 cryoprotected precipitant mixes and 3 buffer systems to form the 3D grid (see Figure 1).

MORPHEUS III Fig 1
Figure 1. MORPHEUS III represented according to the standard 96-condition screen layout: a 3D grid composed of cryoprotecting precipitant mixes (e.g. PEG 4000 with glycerol), 3 buffer systems (pH 6.5, 7.5 and 8.5) and 8 additive mixes (Dipeptides, Vitamins, Nucleosides, etc.).

The set of single compounds can be found in an additive screen called HIPPOCRATES. LifeArc commercialised MORPHEUS® and HIPPOCRATES screens under an exclusive licence to Molecular Dimensions.

Gorrec, F. (2009)
The Morpheus protein crystallisation screen.
J Appl Cryst 7, 1035-1042.

Gorrec, F. (2015)
The Morpheus II protein crystallisation screen.
Acta Cryst F 71, 831-837.

Gorrec, F. and Zinzalla, G. (2018)
The MORPHEUS III protein crystallization screen: at the frontier of drug discovery.
IUCr Newsletter 26.

Primary Sidebar

Research

  • Goals and Research Focus
  • Cell Biology
  • Neurobiology
    • Initiative with the Department of Clinical Neurosciences
  • Protein and Nucleic Acid Chemistry
    • Centre for Chemical and Synthetic Biology
  • Structural Studies
  • Molecular Immunity Unit
  • Technology Transfer
    • History Of Technology Transfer
    • Neonatal Mouse Anaesthetisation Mould Request Form
    • Chinlab Software
    • Examples of Recent Technology Transfer Initiatives
      • Bicycle Therapeutics
      • Mesolens Microscopy
      • Gold EM Support Grids
      • In Vitro Compartmentalization (IVC)
      • CombiPuck
      • SiR (Self-inactivating Rabies virus)
      • MORPHEUS III
      • Trim-Away
      • PepGen
      • Raphin 1
      • Transgenic mice expressing human P301S tau protein (continued success since 2002)
      • Therapeutic Antibodies
  • Scientific Facilities & Support Services
    • Biological Services Group
    • Biophysics
    • Crystallisation and X-ray
    • Electron Microscopy
    • Flow Cytometry
    • Light Microscopy
    • Mass Spectrometry
    • Nanobody
    • NMR
    • Scientific Computing
    • Workshops
    • Support Services
  • Technician Commitment
  • Locally Developed Software
    • Image Processing Software
  • Scientific Training
    • Electron Microscopy
    • Biophysics Lectures
    • Macromolecular Crystallisation
    • Crystallography Course 2013
    • Statistics Course 2014
    • RNA-seq course 2020
  • Published Research
  • Animal Research
    • Why is animal research needed?
    • Alternatives to using Animals in Research
    • Welfare and ethics
    • LMB Research Involving Animals
    • LMB Animal Research Facts and Figures
    • Biological Services Group
    • Concordat on Openness in Animal Research
    • Useful Links
  • Blue Sky Collaboration
  • LMB COVID-19 response

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed. Ok